Octapeptide that reduces the depth of wrinkles caused by facial muscle contractions, being a topical alternative to injections.
Mechanism of action
This new analogue of N-terminal SNAP-25, which follows the revolutionary ARGIRELINE® peptide, competes with natural proteins to be positioned in the SNARE Complex, which is destabilised. As a result, it reduces neuronal excitability and, therefore, muscle contraction.
By reducing muscle contractions, wrinkle depth is reduced up to 63% in one month of treatment. Fine lines and expression wrinkles fade, and the face look smoother.
Lipotec develops active ingredients for the personal care industry and supplies them to leading cosmetic product manufacturers and brand owners worldwide.
The information contained in Lipotec's intranet is exclusively addressed to personal care industry professionals and access to specific data will be granted according to user profile (customers, distributors, consultants, media...).